Trial Information

Summary: A5235: PHASE II, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF MINOCYCLINE IN THE TREATMENT OF HIV-ASSOCIATED COGNITIVE IMPAIRMENT

HIV positive adults needed:

Are you HIV positive and having trouble with memory loss, concentration, thinking, learning or judgment? You may be eligible to participate in a research trial at the MGH AIDS Clinical Trials Unit to test the effects of Minocycline in the treatment of HIV Cognitive Impairment. The trial lasts 48 weeks. You may earn up to $650 upon completion of the study. For more information call (617) 726-3819.

Contact:

Theresa Flynn, RN, ANP
MGH - Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
Telephone: 617-726-3819
Email:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: September 2, 2008 at 2:16:40 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA